Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Susan G who wrote (59787)	9/7/1999 11:30:00 AM
From: kendall harmon	Read Replies (1) \| Respond to of 120523

AFFX news today biz.yahoo.com <<SANTA CLARA, Calif., Sept. 7 /PRNewswire/ -- Affymetrix, Inc. (Nasdaq: AFFX - news), today announced the first commercial shipment of GeneChip® probe arrays from its newest manufacturing facility in West Sacramento, California. This facility will expand current manufacturing capabilities for Affymetrix' GeneChip technology to meet growing customer demand. ''We are pleased with the Company's progress in completing the validation and beginning the scale up of our new manufacturing operations in Sacramento. Sacramento is our first facility that was designed and built from the ground up expressly for the efficient manufacture of GeneChip probe arrays. Over time, we intend to produce the majority of our new and existing products at this facility, while our Sunnyvale site transitions its focus to product and process development,'' said Ronald D. Verdoorn, Executive Vice President of Worldwide Manufacturing Operations at Affymetrix. ''We look forward to increasing our capacity at this location by adding more equipment and building out the unimproved portions of this facility to meet the increasing demands for Affymetrix' GeneChip arrays.'' The portion of the West Sacramento manufacturing facility that commenced commercial operations occupies approximately 35,000 square feet of manufacturing operations and office space. Plans are currently being evaluated to further expand capacity at this facility. Affymetrix has developed and intends to establish its GeneChip system as the platform of choice for acquiring, analyzing and managing complex genetic information in order to improve the diagnosis, monitoring and treatment of disease. The Company's GeneChip system consists of disposable DNA probe arrays containing gene sequences on a chip, reagents for use with the probe arrays, a scanner and other instruments to process the probe arrays, and software to analyze and manage genetic information.>>